La vendita allo scoperto per Cullinan Therapeutics dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Cullinan Therapeutics. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Cullinan Therapeutics (NASDAQ:CGEM) Azioni, Report sulle vendite allo scoperto

Cullinan Therapeutics

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics Inc

Capgemini SE

KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) has outperformed the market over the past 10 years by 7.24% on an annualized basis producing an average annual return of 17.49%. Currently, KKR has a market capitalization of $101.39 billion. 
Buying $1000 In KKR: If an investor had bought $1000 of KKR stock 10 years ago, it would be worth $5,021.96 today based on a price of $114.15 for KKR at the time of writing.
<h3>KKR's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745962239_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much $1000 Invested In KKR 10 Years Ago Would Be Worth Today

Seagate Technology Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) released its third-quarter results after Tuesday's closing bell. Here's a look at the details<a href="https://www.benzinga.com/pressreleases/25/04/b45082722/seagate-technology-reports-fiscal-third-quarter-2025-financial-results"> from the quarter. </a>
The Details: Seagate Technology reported quarterly earnings of $1.90 per share, which missed the analyst consensus estimate of $2.09. Quarterly revenue of $2.16 billion missed the consensus estimate of $2.31 billion and is an increase over sales of $1.66 billion from the same period last year.
Read Next: <a href="https://www.benzinga.com/news/legal/25/04/45056354/alexandria-ocasio-cortez-askshow-much-did-majorie-taylor-greene-make-when-she-bought-the-dip?utm_source=articleShare">Alexandria Ocasio-Cortez Asks,&#8217;How Much Did Majorie Taylor Greene Make When She Bought The Dip?&#8217;</a>
Seagate&#8217;s board of directors declared a quarterly cash dividend of 72 cents per share payable on July 8, 2025, to shareholders of record as of the close of business on June 25, 2025.
&#8220;Seagate delivered another solid quarter of profitable year-on-year growth and margin expansion, elevating our non-GAAP EPS to the top of our guidance range. Our performance underscores the structural enhancements we&#8217;ve made to our business model and healthy supply/demand environment for mass capacity storage,&#8221; said Dave Mosley, Seagate&#8217;s CEO. 
Outlook: Seagate sees fourth-quarter adjusted earnings of between $2.20 and $2.60 per share, versus the $2.20 analyst estimate, and revenue in a range of $2.25 billion to $2.55 billion, versus the $2.43 billion estimate.
STX Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Seagate stock was up 7.87% after hours at $88.02 on Tuesday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/04/45076599/sell-in-may-and-go-away-only-in-bear-markets-one-expert-says?utm_source=articleShare">&#8216;Sell In May And Go Away?&#8217; Only In Bear Markets, One Expert Says&nbsp;</a></li>
</ul>
Photo: Shutterstock

Earnings

Guidance

After-Hours Center

Movers

Tech

Seagate Technology Shares Climb After Q3 Results, Q4 EPS Guidance Above Estimates

TPG RE Finance Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRTX#NYSE">TRTX</a>) reported quarterly earnings of $0.24 per share which missed the analyst consensus estimate of $0.25 by 4 percent. This is a 20 percent decrease over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $37.03 million which beat the analyst consensus estimate of $25.00 million by 48.13 percent. This is a 4.87 percent decrease over sales of $38.93 million the same period last year.

Earnings Beats

Earnings Misses

TRTX

TPG RE Finance Trust Q1 Adj. EPS $0.24 Misses $0.25 Estimate, Sales $37.03M Beat $25.00M Estimate

MSTR moved up over 10 points for the session
<figure class="wp-block-image size-large"><img decoding="async" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/29202454/Screenshot-2025-04-29-at-4.24.40%E2%80%AFPM-958x1024.png" alt="" class="wp-image-11888" /></figure>
MicroStrategy, Inc. (MSTR) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:12 AM on April 29th, a significant trading signal occurred for MicroStrategy, Inc. (MSTR) as it demonstrated a Power Inflow at a price of $373.20. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in MicroStrategy&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in MicroStrategy&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for MSTR, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts. 
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://tradepulse.net/?utm_source=benzinga&amp;utm_medium=article&amp;utm_campaign=brand_awareness_apr2025">https://tradepulse.net/?utm_source=benzinga&amp;utm_medium=article&amp;utm_campaign=brand_awareness_apr2025</a>, which are responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:
The price at the time of the Power Inflow was $373.20. The returns on the High price ($383.89) and Close price ($381.43) after the Power Inflow are respectively 2.9% and 2.2%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite.
Results are not indicative of future results

Equities

WIIM

Technicals

Opinion

Signals

MicroStrategy Stock Up 2.9% After Key Signal At 10:12 AM

New Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NGD#AMEX">NGD</a>) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $0.01 by 100 percent. This is unchanged from the same period last year. The company reported quarterly sales of $209.10 million which beat the analyst consensus estimate of $166.58 million by 25.53 percent. This is a 8.85 percent increase over sales of $192.10 million the same period last year.

New Gold Q1 Adj. EPS $0.02 Beats $0.01 Estimate, Sales $209.10M Beat $166.58M Estimate

Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) <a target="_blank" href="https://www.benzinga.com/topic/ecommerce" rel="noreferrer noopener">canvassed its suppliers</a> to offer low, double-digit discounts on homeware to consumer electronics as U.S. President Donald Trump&#8217;s tariffs kicked in.
The Trump administration imposed tariffs of up to 145% on China, prompting Amazon to deal more aggressively with suppliers sourcing from China, the Financial Times <a target="_blank" href="https://www.ft.com/content/0363e639-07de-4b6b-84f8-82733bc3afc7" rel="noreferrer noopener">reported</a> Tuesday, citing vendor consultants. The tariffs also affected vendors from other countries.
Benzinga has reached out to Amazon for comments and will update the story.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/45012329/amazon-sellers-hike-prices-on-essentials-as-trumps-china-tariffs-squeeze-margins" rel="noreferrer noopener">Amazon Sellers Hike Prices On Essentials As Trump China Tariffs Squeeze Margins</a>
Amazon took a cue from rivals like Costco Wholesale Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) and Walmart Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) move as they attempted to protect their margins, which they did in response to Trump&#8217;s first term in office.
Goldman Sachs analysts told the Financial Times that it expects the tariffs to affect 6%-12% of Amazon&#8217;s operating margins in 2025.
Several logistics providers and analysts told the Financial Times that Amazon had brought forward shipments and had pivoted to purchasing goods from suppliers with U.S. stock as Trump took charge in January.
Amazon had taken a less aggressive stance elsewhere, offering to bear up to a third of tariffs on non-China imports, which were at 10% during a 90-day pause period, the Financial Times cited consultants.
Analysts will closely follow Amazon Prime Day, which occurs twice a year in July and October. The summer edition generated $14.2 billion in 2024, the Financial Times cited Adobe Analytics. However, this year&#8217;s event will likely feature less steep discounts.
The White House criticized Amazon for reportedly <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/04/45067585/amazon-stock-tumbles-as-white-house-calls-tariff-visibility-plans-a-hostile-act" rel="noreferrer noopener">planning to display</a> the cost of tariffs next to the total price of products on its site, CNBC <a target="_blank" href="https://www.cnbc.com/2025/04/29/white-house-blasts-amazon-over-tariff-cost-report-hostile-and-political-act.html" rel="noreferrer noopener">reported</a> Tuesday. Close to 70% of products sold by Amazon are made in China.&nbsp;
White House press secretary Karoline Leavitt drew parallels with the Biden administration hiking inflation to &#8220;record levels in 40 years&#8221;.
Amazon denied the report, citing its plans to reveal the tariff cost it added to its products.
Separately, Jeff Stein of the Washington Post <a target="_blank" href="https://x.com/JStein_WaPo/status/1917220665821634689" rel="noreferrer noopener">tweeted</a> that Amazon Haul has considered listing import price duties on certain products, something it had never considered for the main website.
Price Action:&nbsp;Amazon stock closed lower by 0.17% to $187.39 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/45014074/apple-plans-iphone-shift-from-china-to-india-amid-tariff-pressures-geopolitical-risks" target="_blank" rel="noreferrer noopener">Apple Plans iPhone Shift From China To India Amid Tariff Pressures, Geopolitical Risks: Report</a></li>
</ul>
Photo by Markus Mainka via Shutterstock

Media

AMZN

COST

Amazon Pressures Suppliers For Discounts, May Show Tariff Related Costs On Haul Site

Riverview Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVSB#NASDAQ">RVSB</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 25 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $12.90 million which beat the analyst consensus estimate of $12.40 million by 4.03 percent. This is a 42.60 percent increase over sales of $9.05 million the same period last year.

RVSB

Riverview Bancorp Q4 EPS $0.05 Beats $0.03 Estimate, Sales $12.90M Beat $12.40M Estimate

Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares are tanking in Tuesday&#8217;s after-hours session after the company reported preliminary results for its <a href="https://www.benzinga.com/pressreleases/25/04/b45084091/supermicro-provides-third-quarter-fiscal-2025-business-update-and-preliminary-financial-results">fiscal third quarter</a>.
What Happened: Super Micro reported weak preliminary results for the third quarter after market close, citing delayed customer platform decisions that moved sales into the fourth quarter.
The company now expects to report third-quarter revenue of $4.5 billion to $4.6 billion, down from prior guidance of $5 billion to $6 billion. Super Micro also expects third-quarter adjusted earnings to be in the range of 29 cents to 31 cents per share, down from prior guidance of 46 cents to 62 cents per share. 
Super Micro further noted that GAAP and non-GAAP gross margin for the third quarter was 220 basis points lower than the second quarter, primarily due to &#8220;higher inventory reserves resulting from older generation products and expedite costs to enable time-to-market for new products.&#8221;
One bright spot from the release is that new generation product designs were &#8220;robust,&#8221; the company said.
Super Micro will report audited results for the <a href="https://www.benzinga.com/calendars/earnings">third quarter</a> after the market close on May 6. Company executives will further discuss the shortfall on a conference call scheduled for 5 p.m. ET that day. 
<a href="http://benzinga.com/quote/smci">Super Micro Computer shares</a> were down 16.64% after hours, trading at $30.05 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Other chip companies were facing selling pressure following the preliminary release, including NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), down 1.84%; Micron Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), down 1.86% and Dell Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>), down 4.87% at $89.21 for after-hours Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/04/45033025/nvidia-faces-new-challenge-as-huawei-tests-powerful-ascend-910d-ai-chip-amid-us-sanctions-aiming-to-disrupt-high-end-market-report">Nvidia Faces New Challenge As Huawei Tests Powerful Ascend 910D AI Chip Amid US Sanctions, Aiming To Disrupt High-End Market: Report</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/jackpress">jackpress</a>/Shutterstock.

DELL

NVDA

SMCI

Super Micro Computer Stock Is Tanking After Hours: What's Fueling The Sell-Off?

Polaris Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>) reported its first quarter 2025 results on Tuesday.
Polaris <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n45061142/polaris-inc-first-quarter-2025-financial-results-available-on-companys-website" rel="noreferrer noopener">reported </a>a first-quarter adjusted loss of 90 cents per share, beating the <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">street view of 91 cents loss</a>. Quarterly sales of $1.54 billion (down 12% year over year) were in line with the analyst consensus estimate.
Primary factors affecting first-quarter sales were lower volume due to planned shipment reductions and lower net pricing driven by higher promotional spend.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44876406/retail-slowdown-and-tariff-turbulence-hit-leisure-stocks-says-analyst" rel="noreferrer noopener">Retail Slowdown, Tariffs Jolt Leisure Stocks: Analyst Revises Estimates For Topgolf, Harley-Davidson And More</a>
North America sales of $1.290 billion (down 11% year over year) represented 84 percent of total sales. International sales of $246 million (down 16% year over year) represented 16% of total sales.
&#8220;While consumer uncertainty and a dynamic tariff environment are near-term hurdles, we are thoughtfully navigating these challenges,&#8221; said Mike Speetzen, Chief Executive Officer of Polaris. However, the company noted minimal first-quarter tariff impact due to timing.
The adjusted gross profit margin of 16.6% decreased by 242 basis points, primarily due to higher promotional activity and negative foreign exchange.
Operating expenses were $303 million in the first quarter of 2025 compared to $313 million in the year-ago period.
Polaris exited the quarter with cash and equivalents worth $291.7 million and inventories of $1.748 billion.
Outlook: The company introduced second-quarter 2025 sales guidance of $1.6 billion to $1.8 billion versus the $1.820 billion estimate.
Polaris said it is withdrawing the full-year 2025 guidance due to trade and economic uncertainty.
Price Action: PII shares traded higher by 0.27% to $33.83&nbsp;on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/45059922/uber-orders-employees-back-to-office-three-days-a-week-good-is-not-going-to-be-good-enough-ceo-says" target="_blank" rel="noreferrer noopener">Uber Orders Employees Back To Office 3 Days A Week: Good &#8216;Is Not Going To Be Good Enough,&#8217; Says CEO Dara Khosrowshahi</a></li>
</ul>
Photo by Steve Skjold via Shutterstock

Markets

General

Polaris Q1 Sales Fall, CEO Warns Of 'Consumer Uncertainty' And 'Dynamic Tariff Environment' As Near-term Hurdles

<a href="https://api.mziq.com/mzfilemanager/v2/d/83a9acb7-4ada-4a58-97e4-257b49aec76b/4f84edfe-08f2-6818-e184-5a691b3f6cd8?origin=1">https://api.mziq.com/mzfilemanager/v2/d/83a9acb7-4ada-4a58-97e4-257b49aec76b/4f84edfe-08f2-6818-e184-5a691b3f6cd8?origin=1</a>

Trump Media & Technology Publishes Letter to Shareholders; Says Looking Ahead, Assessing Various Means Of Monetizing Truth+ Platform; Says In Near Future, Plans To Offer Premium Features On Truth Social Platform To Subscribers Of Truth+ Streaming Service

<h3>Gainers</h3>
<ul>
<li>Magic Empire Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEGL#NASDAQ">MEGL</a>) shares rose 11.3% to $1.4 during Tuesday's after-market session. The company's market cap stands at $5.7 million. </li>
<li>Patriot Ntl Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNBK#NASDAQ">PNBK</a>) stock rose 8.9% to $4.28. The company's market cap stands at $315.5 million. </li>
<li>Maiden Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHLD#NASDAQ">MHLD</a>) stock increased by 7.25% to $1.33. The market value of their outstanding shares is at $132.3 million. </li>
<li>Future FinTech Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTFT#NASDAQ">FTFT</a>) shares moved upwards by 5.81% to $1.6. The market value of their outstanding shares is at $4.8 million. </li>
<li>Advanced Flower Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFCG#NASDAQ">AFCG</a>) shares moved upwards by 4.88% to $5.58. The market value of their outstanding shares is at $126.0 million. </li>
<li>ACRES Commercial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACR#NYSE">ACR</a>) stock rose 4.59% to $20.04. The company's market cap stands at $148.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Prestige Wealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWM#NASDAQ">PWM</a>) shares declined by 9.1% to $0.39 during Tuesday's after-market session. The market value of their outstanding shares is at $12.4 million. </li>
<li>Unum Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNM#NYSE">UNM</a>) shares decreased by 8.54% to $72.48. The company's market cap stands at $12.8 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) shares fell 7.16% to $8.3. The market value of their outstanding shares is at $334.7 million. As per the news, the Q1 earnings report came out today. </li>
<li>Powell Max (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMAX#NASDAQ">PMAX</a>) stock decreased by 6.42% to $0.38. The company's market cap stands at $5.5 million. The company's, FY earnings came out yesterday. </li>
<li>LendingClub (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>) shares declined by 6.09% to $10.34. The market value of their outstanding shares is at $1.1 billion. As per the press release, Q1 earnings came out today. </li>
<li>Triller Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILLR#NASDAQ">ILLR</a>) shares declined by 4.73% to $1.31. The company's market cap stands at $198.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AFCG

FTFT

HRZN

ILLR

MEGL

MHLD

PMAX

PNBK

12 Financials Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Mobile-health Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) shares rose 26.8% to $1.8 during Tuesday's after-market session. The company's market cap stands at $7.8 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock moved upwards by 17.85% to $0.2. The company's market cap stands at $5.1 million. </li>
<li>Aspire Biopharma Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASBP#NASDAQ">ASBP</a>) shares moved upwards by 9.09% to $0.51. The company's market cap stands at $24.8 million. </li>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) stock rose 9.03% to $0.59. The company's market cap stands at $3.5 million. </li>
<li>Radiopharm Theranostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RADX#NASDAQ">RADX</a>) stock rose 7.69% to $4.2. The market value of their outstanding shares is at $32.6 million. </li>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) shares rose 7.29% to $0.44. The company's market cap stands at $4.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) shares declined by 17.7% to $0.25 during Tuesday's after-market session. The market value of their outstanding shares is at $3.4 million. </li>
<li>Akari Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTX#NASDAQ">AKTX</a>) shares decreased by 16.43% to $1.17. The company's market cap stands at $33.7 million. </li>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) stock declined by 8.38% to $0.2. The market value of their outstanding shares is at $1.4 million. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) stock decreased by 7.66% to $0.24. The company's market cap stands at $12.5 million. </li>
<li>BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) shares declined by 7.55% to $2.82. The market value of their outstanding shares is at $12.9 million. </li>
<li>LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) stock declined by 7.37% to $0.02. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEON

AKTX

ASBP

BCDA

CYCC

GCTK

LGMK

MNDR

NCNA

PTIX

RADX

12 Health Care Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Kforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NYSE">KFRC</a>) shares moved upwards by 31.2% to $48.0 during Tuesday's after-market session. The market value of their outstanding shares is at $917.3 million. The company's, Q1 earnings came out yesterday. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) shares moved upwards by 22.33% to $1.26. The market value of their outstanding shares is at $21.8 million. </li>
<li>Global Industrial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIC#NYSE">GIC</a>) shares increased by 11.22% to $24.68. The company's market cap stands at $946.7 million. The company's, Q1 earnings came out today. </li>
<li>Orion Group Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORN#NYSE">ORN</a>) shares rose 10.58% to $7.0. The company's market cap stands at $272.9 million. As per the press release, Q1 earnings came out today. </li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) shares increased by 8.76% to $0.87. The company's market cap stands at $5.2 million. </li>
<li>Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) shares rose 5.68% to $0.29. The market value of their outstanding shares is at $8.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>AirJoule Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRJ#NASDAQ">AIRJ</a>) shares fell 9.3% to $4.6 during Tuesday's after-market session. The market value of their outstanding shares is at $259.6 million. </li>
<li>Wabash National (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNC#NYSE">WNC</a>) stock decreased by 9.24% to $9.04. The company's market cap stands at $382.2 million. </li>
<li>Vicor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VICR#NASDAQ">VICR</a>) shares declined by 8.96% to $47.26. The market value of their outstanding shares is at $2.1 billion. As per the press release, Q1 earnings came out today. </li>
<li>SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) shares decreased by 5.23% to $0.92. The company's market cap stands at $333.8 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>Werner Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WERN#NASDAQ">WERN</a>) shares declined by 4.74% to $26.35. The company's market cap stands at $1.6 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Sentage Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTG#NASDAQ">SNTG</a>) stock fell 4.74% to $1.61. The company's market cap stands at $4.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRJ

ATXG

KFRC

SNTG

VICR

WATT

WERN

ZBAI

12 Industrials Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Nvni Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) stock rose 21.2% to $0.26 during Tuesday's after-market session. The company's market cap stands at $23.7 million. </li>
<li>Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) shares rose 11.57% to $16.0. The company's market cap stands at $4.7 billion. The company's, Q1 earnings came out today. </li>
<li>E2open Parent Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) shares increased by 9.52% to $2.3. The company's market cap stands at $711.4 million. As per the news, the Q4 earnings report came out today. </li>
<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares increased by 8.96% to $0.67. The company's market cap stands at $2.1 million. </li>
<li>Qorvo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) stock moved upwards by 8.21% to $67.76. The market value of their outstanding shares is at $6.3 billion. The company's, Q4 earnings came out today. </li>
<li>Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) stock moved upwards by 7.84% to $88.0. The market value of their outstanding shares is at $18.6 billion. As per the press release, Q3 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares decreased by 16.4% to $30.09 during Tuesday's after-market session. The market value of their outstanding shares is at $17.9 billion. </li>
<li>Ribbon Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBBN#NASDAQ">RBBN</a>) shares fell 12.5% to $3.29. The company's market cap stands at $578.8 million. The company's, Q1 earnings came out today. </li>
<li>Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) shares fell 10.93% to $30.0. The market value of their outstanding shares is at $3.6 billion. As per the press release, Q1 earnings came out today. </li>
<li>First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) shares declined by 9.16% to $124.67. The company's market cap stands at $13.3 billion. As per the press release, Q1 earnings came out today. </li>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) shares declined by 6.95% to $0.25. The company's market cap stands at $17.3 million. </li>
<li>Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) stock decreased by 6.47% to $0.42. The market value of their outstanding shares is at $26.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARBK

ETWO

FRSH

FSLR

GRYP

MRIN

NVNI

QRVO

RBBN

TENB

12 Information Technology Stocks Moving In Tuesday's After-Market Session

CTKB

Cytek Biosciences Showcases Its Patented Full Spectrum Profiling Technology at CYTO and IMMUNOLOGY2025

Primis Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRST#NASDAQ">FRST</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.25 by 44 percent. This is a 46.15 percent decrease over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $34.12 million which beat the analyst consensus estimate of $26.88 million by 26.93 percent. This is a 20.42 percent decrease over sales of $42.87 million the same period last year.

FRST

Primis Finl Q1 Adj. EPS $0.14 Misses $0.25 Estimate, Sales $34.12M Beat $26.88M Estimate

Littelfuse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFUS#NASDAQ">LFUS</a>) is looking for Q2 Adj EPS of $2.10-$2.40 vs $2.26 analyst estimate. sees sales of $565.000 million-$595.000 million vs $579.56 million analyst estimate.

LFUS

Littelfuse Sees Q2 Adj EPS $2.10-$2.40 vs $2.26 Est; Sees Sales $565.000M-$595.000M vs $579.56M Est

Qorvo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) released its fourth-quarter results after Tuesday's closing bell. Here's a look at the details<a href="https://www.benzinga.com/pressreleases/25/04/g45082146/qorvo-announces-fiscal-2025-fourth-quarter-financial-results"> from the report. </a>
The Details: Qorvo reported quarterly earnings of $1.42 per share, which beat the analyst consensus estimate of $1.00 by 42%. Quarterly revenue clocked in at $869.5 million, beating the consensus estimate of $850.39 million.
Read Next: <a href="https://www.benzinga.com/news/legal/25/04/45056354/alexandria-ocasio-cortez-askshow-much-did-majorie-taylor-greene-make-when-she-bought-the-dip?utm_source=articleShare">Alexandria Ocasio-Cortez Asks,&#8217;How Much Did Majorie Taylor Greene Make When She Bought The Dip?&#8217;</a>
&#8220;During the March quarter, Qorvo achieved stronger than seasonal sequential revenue while surpassing the midpoint of EPS guidance by 42 cents and expanding gross margin year-over-year. Looking across our business segments, our growth and margin targets are anchored in a multi-year strategy focused on winning content with our largest customer and building on our core RF and power expertise to drive diversification through CSG and HPA,&#8221; Bob Bruggeworth, CEO of Qorvo, said.
Outlook:&nbsp;Qorvo is looking for&nbsp;first-quarter adjusted earnings of between 50 cents and 75 cents per share, versus the 59 cent estimate, and revenue in a range of $750 million to $800 million, versus the $756.37 million analyst estimate. 
QRVO Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Qorvo stock was up 10.14% after-hours at $69 on Tuesday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/04/45076599/sell-in-may-and-go-away-only-in-bear-markets-one-expert-says?utm_source=articleShare">&#8216;Sell In May And Go Away?&#8217; Only In Bear Markets, One Expert Says&nbsp;</a></li>
</ul>
Photo: Shutterstock

Qorvo Stock Rallies After Solid Q4 Results, Strong Q1 Guidance

Rehlko Enters Exclusive Deal with Toyota to Provide Fuel Cell Modules

Medallion Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFIN#NASDAQ">MFIN</a>) is preparing to release its quarterly earnings on Wednesday, 2025-04-30. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Medallion Finl to report an earnings per share (EPS) of $0.32.
The announcement from Medallion Finl is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Earnings Track Record</h3>
The company's EPS beat by $0.10 in the last quarter, leading to a 7.22% increase in the share price on the following day.
Here's a look at Medallion Finl's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.33</td>
<td>0.37</td>
<td>0.35</td>
<td>0.36</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.43</td>
<td>0.37</td>
<td>0.30</td>
<td>0.42</td>
</tr>
<tr>
<td>Price Change %</td>
<td>7.000000000000001%</td>
<td>-1.0%</td>
<td>3.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745960524_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Medallion Finl were trading at $8.76 as of April 28. Over the last 52-week period, shares are up 14.05%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/MFIN/earnings">To track all earnings releases for Medallion Finl visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MFIN

Uncovering Potential: Medallion Finl's Earnings Preview

Press Releases

Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Analyst Ratings

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024

Clear Street Launches Healthcare & Biotechnology Equity Research

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy

Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Health Care

Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis

Cullinan Therapeutics to Present Results from REZILIENT1, a Phase 1/2 Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy, at ASCO 2025

Cullinan Therapeutics to Initiate Study of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Sjögren's Disease in the United States

Comments

Cullinan Therapeutics

Vendite allo scoperto

Cullinan Therapeutics (NASDAQ:CGEM) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO